The FDA has approved the first gene treatment for a fatal form of muscular dystrophy in children.
The first gene therapy for a deadly form of muscular dystrophy received…
Sarepta’s gene therapy for rare muscular dystrophy in some children has received US FDA approval.
The U.S. drug regulator on Thursday granted accelerated approval to Sarepta Therapeutics'…